News
Marie Curie Award of the EANM to ABX-CRO and ITM for Dosimetry Excellence
ABX-CRO and ITM (Isotope Technologies Munich) have been awarded the prestigious Marie Curie Award of the European Association of Nuclear Medicine (EANM) for outstanding research contributions in nuclear medicine.
The award recognizes the dosimetry work performed as part of the COMPETE study - a controlled, open-label clinical trial investigating ITM-11 (n.c.a. 177Lu-DOTATOC) in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NET).
ABX-CRO provided comprehensive clinical dosimetry services for the study using its in-house QDOSE software platform, delivering organ-level and tumour dose assessments across multiple imaging timepoints and clinical sites.
The Marie Curie Award is one of the most prestigious recognitions in European nuclear medicine, and this award underscores ABX-CRO's position as a leader in clinical dosimetry for radiopharmaceutical development.
